drugset / Trial / NCT01444248
Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
The study design of this trial is open-label, randomized, multi-center, parallel-group study.
Timeline
- Start
- 2010-08
- Primary completion
- 2011-12
- Completion
- 2012-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Glimepiride | Small molecule | 4 mg | Oral |
| Comparator | Metformin | Small molecule | 1000 mg | Oral |